Deputy Director of Cardiology, Head of Coronary Artery Disease Group, Chief Physician
Cardio-Cerebrovascular
Research areas : interventional treatment of complex and high-risk coronary arteries; intravascular coronary imaging (IVUS); chronic occlusive disease (CTO). Cutting-edge technologies: The first complex high-risk PCI in China supported by a domestically produced transcatheter left ventricular pump assist device; the first in Southwest China to carry out complex coronary interventions and high-speed rotational atherectomy under intravascular ultrasound guidance; CTO retrograde interventional treatment and
Affiliated Hospital
West China Hospital of Sichuan University
→
Chief Physician, Doctoral Supervisor | Head of the Arrhythmia Subspecialty Group
Cardio-Cerebrovascular
Research areas: atrial fibrillation, ventricular arrhythmias, complex tachyarrhythmias; Cutting-edge technologies: 3D mapping radiofrequency ablation, pulsed electric field ablation, one-stop surgery for atrial fibrillation (ablation + left atrial appendage occlusion); Academic Highlights: Deputy Head of the Left Atrial Appendage Occlusion Group of the Chinese Society of Cardiac Electrophysiology and Pacing; specializes in ablation of ventricular tachycardia in organic heart disease, has presided over mul
Affiliated Hospital
West China Hospital of Sichuan University
→
Deputy Director of the Coronary Artery Disease Center, specializing in intravascular imaging and QFR
Cardio-Cerebrovascular
Research areas: Coronary artery disease and complex coronary interventional treatment, intravascular imaging and physiology of the coronary arteries. Cutting-edge technology: Co-first author of the FAVOR III China study published in *The Lancet* (impact factor 207), confirming that QFR-guided coronary intervention can significantly improve prognosis. Invited by *The Lancet* as the sole author from China to participate in writing a major global report on "Ischemic Heart Disease". Drafted the National Healt
Affiliated Hospital
Fuwai Hospital, Chinese Academy of Medical Sciences
→
Professor, Doctoral Supervisor, Department Head
Cardio-Cerebrovascular
- Research areas: Congenital heart disease surgery, heart transplantation, end-stage heart failure surgery; - Core technologies: Complex congenital heart disease correction in infants and young children, heart transplantation; - Areas of expertise: Various complex congenital heart diseases, dilated cardiomyopathy, and end-stage heart failure; - Academic Value: President of the Cardiovascular Surgery Branch of the Sichuan Provincial Medical Association, Standing Committee Member of the Congenital Heart Dis
Affiliated Hospital
West China Hospital of Sichuan University
→
Professor, Doctoral Supervisor, Deputy Director of Department (Academic Leader of the Coronary Artery Surgery and Chronic Pulmonary Embolism Surgery Subspecialty)
Cardio-Cerebrovascular
- Research areas: aortic disease, chronic thromboembolic pulmonary hypertension; coronary artery bypass grafting for coronary heart disease; surgical treatment of chronic thromboembolic pulmonary hypertension (CTEPH); valvular heart disease, aortic aneurysm, chronic atrial fibrillation. - Core technologies: Sun's procedure for aortic dissection, coronary artery bypass grafting; pulmonary endarterectomy (PEA) - first to be routinely performed in Southwest China, filling the technological gap in West China
Affiliated Hospital
West China Hospital of Sichuan University
→
Aortic Surgery and Neuroprotection
Cardio-Cerebrovascular
Research areas: Surgical clinical and basic research on aortic diseases, with a focus on treatment systems for the root of type A aortic dissection, repair strategies for bicuspid aortic valve malformation, and new paradigms for the treatment of the neurological system in aortic arch surgery. Cutting-edge technology: In 2017, the institute pioneered the application of aortic balloon occlusion technology to total aortic arch replacement and stent elephant trunk surgery, shortening the deep hypothermic circ
Affiliated Hospital
Fuwai Hospital, Chinese Academy of Medical Sciences
→
Director of the Arrhythmia Center, specializing in ablation of complex arrhythmias
Cardio-Cerebrovascular
Research focus: Mechanism study and catheter ablation therapy for complex and difficult arrhythmias. Cutting-edge technology: Maintaining an annual ablation procedure volume of over 1000 complex and difficult cases, ranking first internationally, with a cumulative total of nearly 30,000 cases. The number of ARVC ventricular tachycardia ablation cases is the largest series in the world; the number, difficulty, and success rate of organic ventricular tachycardia ablation cases are the highest in China. A un
Affiliated Hospital
Fuwai Hospital, Chinese Academy of Medical Sciences
→
Director of Cardiac and Vascular Surgery, West China Tianfu Hospital; Level III Expert
Cardio-Cerebrovascular
Research areas : Surgical and minimally invasive treatment of valvular heart disease, coronary heart disease, and major vascular diseases; infective endocarditis, atrial fibrillation, and cardiac tumors. Specializes in treating: valvular heart disease, coronary heart disease, major vascular diseases, and congenital heart disease in adults. Academic Highlights: Candidate for academic and technical leader of Sichuan Provincial Health Commission; presided over 1 National Natural Science Foundation of China p
Affiliated Hospital
West China Hospital of Sichuan University
→
Head of the Congenital Heart Disease Subspecialty Group, Chief Physician, Doctoral Supervisor
Cardio-Cerebrovascular
Research areas : interventional treatment of structural heart disease; congenital heart disease; pulmonary vascular intervention. Cutting-edge technology: In 2014, a joint hybrid cardiac surgery was performed on a 9-day-old infant with congenital heart disease; in 2019, the first aortic coarctation stent implantation was performed on a critically ill newborn in China; a participant in the world's first human trial of aortic valve "stem valve" implantation; and conducted international teaching on transcath
Affiliated Hospital
West China Hospital of Sichuan University
→
Chief Physician, Dr., Doctoral Supervisor, Executive Deputy Director of Plastic and Reconstructive Surgery, Director of the Hemangioma and Vascular Malformation Department, and Director of the Laser Cosmetic Department
Cosmetic SurgeryCardio-Cerebrovascular
Leading the first Phase II clinical trial of a targeted drug for extracranial arteriovenous malformations in China (the only clinical trial of an AVM-targeted drug approved by the CDE); establishing an internationally leading PROS/FIL disease cohort and sample bank. With 30 years of experience in the field of hemangiomas and vascular malformations, some patients have experienced a lesion volume reduction rate of over 50% after 16 weeks of treatment with the domestically developed innovative drug FCN-159.
Affiliated Hospital
Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital
→
